Arthri-D3 Name Remains After Testimonials Vanish During NAD Review
This article was originally published in The Tan Sheet
Executive Summary
NAD attorneys agree with CRN that the Arthri-D3 brand, when used in conjunction with testimonials related to relief from arthritis pain, “might convey the misleading message that Arthri-D3 immediately and completely relieves arthritis pain.” However, Arthri-D LLC discontinues the challenged testimonials.
You may also be interested in...
P&G Supports Crest Sensi-Stop Strips Claims In More Than Name Only – NAD
P&G’s Crest Sensi-Stop Strips emerge largely unscathed from a NAD review of claims made in ads and on product packaging. While GSK argued some claims were unsupported, including the product name, NAD determined P&G’s evidence supports claims of immediate relief and protection for up to one month.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.